Evidence map›Paper›PMID 29550027›Full record

ReviewLancet (London, England)2018

Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions.

Shahin Sayed, William Cherniak, Mark Lawler, Soo Yong Tan, Wafaa El Sadr, Nicholas Wolf, Shannon Silkensen, Nathan Brand, Lai Meng Looi, Sanjay A Pai and 4 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lancet (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Shahin SayedDepartment of Pathology, Aga Khan University Hospital Nairobi, Nairobi, Kenya. Electronic address: shaheen.sayed@aku.edu.
William CherniakCenter for Global Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mark LawlerFaculty of Medicine, Health, and Life Sciences and Centre for Cancer Research and Cell Biology, Queens University, Belfast, UK.
Soo Yong TanDepartment of Pathology, National University of Singapore, National University Hospital, Singapore.
Wafaa El SadrICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
Nicholas WolfCenter for Global Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Shannon SilkensenCenter for Global Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nathan BrandVagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Lai Meng LooiDepartment of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Sanjay A PaiColumbia Asia Referral Hospital, Bangalore, Karnataka, India.
Michael L WilsonDepartment of Pathology and Laboratory Services, Denver Health, Denver, CO, USA; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
Danny MilnerAmerican Society for Clinical Pathology, Chicago, IL, USA.
John FlaniganCenter for Global Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kenneth A FlemingCenter for Global Health, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Green Templeton College, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insufficient awareness of the centrality of pathology and laboratory medicine (PALM) to a functioning health-care system at policy and governmental level, with the resultant inadequate investment, has meant that efforts to enhance PALM in low-income and middle-income countries have been local, fragmented, and mostly unsustainable. Responding to the four major barriers in PALM service delivery that were identified in the first paper of this Series (workforce, infrastructure, education and training, and quality assurance), this second paper identifies potential solutions that can be applied in low-income and middle-income countries (LMICs). Increasing and retaining a quality PALM workforce requires access to mentorship and continuing professional development, task sharing, and the development of short-term visitor programmes. Opportunities to enhance the training of pathologists and allied PALM personnel by increasing and improving education provision must be explored and implemented. PALM infrastructure must be strengthened by addressing supply chain barriers, and ensuring laboratory information systems are in place. New technologies, including telepathology and point-of-care testing, can have a substantial role in PALM service delivery, if used appropriately. We emphasise the crucial importance of maintaining PALM quality and posit that all laboratories in LMICs should participate in quality assurance and accreditation programmes. A potential role for public-private partnerships in filling PALM services gaps should also be investigated. Finally, to deliver these solutions and ensure equitable access to essential services in LMICs, we propose a PALM package focused on these countries, integrated within a nationally tiered laboratory system, as part of an overarching national laboratory strategic plan.

Indexed as

Clinical Laboratory ServicesHealth Services Needs and DemandDeveloping CountriesHealth EducationHumansPathologistsPoint-of-Care SystemsPublic HealthQuality of Health CareTelepathologyUniversal Health InsuranceWorkforce

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.